Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Woodman

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2011
BAP1tism of a tumor suppressorScott E Woodman
Cancer Journal (Sudbury, Mass.)|March 29, 2012
Metastatic uveal melanoma: biology and emerging treatmentsScott E Woodman
The Journal of Dermatology|May 19, 2021
The genetic and epigenetic basis of distinct melanoma typesJunna Oba, Scott E Woodman
BMC Genomics|December 2, 2014
HotSpotter: efficient visualization of driver mutationsJason Roszik, Scott E Woodman
Biochemical Pharmacology|May 12, 2010
Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeuticsScott E Woodman, Michael A Davies
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2010
Are oncogenes sufficient to cause human cancer?Scott E Woodman, Gordon B Mills
Drug Design, Development and Therapy|January 24, 2012
Profile of ipilimumab and its role in the treatment of metastatic melanomaSapna P Patel, Scott E Woodman
Pharmacological Reviews|September 12, 2002
Caveolae: from cell biology to animal physiologyBabak Razani, Scott E Woodman, Michael P Lisanti
Cancer Discovery|September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?Guang Peng, Scott E Woodman, Gordon B Mills
Plos One|February 20, 2014
Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migrationChandrani Chattopadhyay, Elizabeth A Grimm, Scott E Woodman
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2011
BAP1tism of a tumor suppressorScott E Woodman
Cancer Journal (Sudbury, Mass.)|March 29, 2012
Metastatic uveal melanoma: biology and emerging treatmentsScott E Woodman
The Journal of Dermatology|May 19, 2021
The genetic and epigenetic basis of distinct melanoma typesJunna Oba, Scott E Woodman
BMC Genomics|December 2, 2014
HotSpotter: efficient visualization of driver mutationsJason Roszik, Scott E Woodman
Biochemical Pharmacology|May 12, 2010
Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeuticsScott E Woodman, Michael A Davies
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2010
Are oncogenes sufficient to cause human cancer?Scott E Woodman, Gordon B Mills
Drug Design, Development and Therapy|January 24, 2012
Profile of ipilimumab and its role in the treatment of metastatic melanomaSapna P Patel, Scott E Woodman
Pharmacological Reviews|September 12, 2002
Caveolae: from cell biology to animal physiologyBabak Razani, Scott E Woodman, Michael P Lisanti
Cancer Discovery|September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?Guang Peng, Scott E Woodman, Gordon B Mills
Plos One|February 20, 2014
Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migrationChandrani Chattopadhyay, Elizabeth A Grimm, Scott E Woodman
Pageof 10